Shareholder Class Action
SAN FRANCISCO (CN) — In a federal class action, shareholders say directors are selling the medical-device company Abaxis too cheaply through an unfair process to Zoetis, for $83 a share or $2 billion.
SAN FRANCISCO (CN) — In a federal class action, shareholders say directors are selling the medical-device company Abaxis too cheaply through an unfair process to Zoetis, for $83 a share or $2 billion.